Cigna Corp. (CI) Tops Q4 EPS by 7c; Guides FY16 EPS Modestly Below the Street
Get Alerts CI Hot Sheet
EPS Growth %: +15.0%
Financial Fact:
Mail order pharmacy revenues: 762M
Today's EPS Names:
FRSB, DGICA, UXIN, More
Join SI Premium – FREE
Cigna Corp. (NYSE: CI) reported Q4 EPS of $1.87, $0.07 better than the analyst estimate of $1.80. Revenue for the quarter came in at $9.53 billion versus the consensus estimate of $9.52 billion.
"The strong results we delivered in 2015 reflect our proven ability to create sustained value for customers and clients," said David M. Cordani, President and Chief Executive Officer. "The effective execution of our global strategy and our differentiated capabilities provide us with strong momentum as we begin 2016. Our pending combination with Anthem will further accelerate our strategy to improve quality, choice, and affordability in the marketplace."
GUIDANCE:
Cigna Corp. sees FY2016 EPS of $8.85-$9.25, versus the consensus of $9.30.
Full-Year Ending | ||
Projected 2016 Growth in: | December 31, 2016 | |
Consolidated Revenue | Mid-single digit percentage range | |
Consolidated Adjusted Income (Loss) from Operations1,2,11 | High single digit percentage range | |
Global Medical Customers10 | Low single digit percentage range |
For earnings history and earnings-related data on Cigna Corp. (CI) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Gilead Sciences (GILD) Misses Q1 EPS by 288c
- SPS Commerce (SPSC) Tops Q1 EPS by 12c
- Allison Transmission (ALSN) Tops Q1 EPS by 2c, Beats on Revenue; Offers FY24 Revenue Guidance
Create E-mail Alert Related Categories
Earnings, Guidance, Hot Earnings, Hot Guidance, Management CommentsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!